P-Cure, a leader in compact proton therapy solutions, has announced the successful completion of the world's first renovation of a standard medical linear accelerator (LINAC) facility into a ...
UNC Health System will integrate the radiation technology into their main campus in Chapel Hill in 2028 to help treat cancer ...
If you would like a patient care coordinator to reach out to you, please fill out our form to schedule an information call. Form: Schedule a Call with a Patient Care Coordinator Proton therapy is an ...
The MEVION S250-FIT is the first and only proton therapy system designed to fit into a standard radiation therapy vault. By enabling cancer centers to use their existing infrastructure, the MEVION ...
Why: Established in 2016, at a time when there were only 13 proton centers across the country and none in the Maryland, DC, and Northern Virigina area, MPTC stood as a pioneer of ...
P-Cure, a supplier of compact, gantry-less proton therapy systems, today announced the first-ever prospective clinical results demonstrating the feasibility, safety, and early efficacy of gantry-less ...
The single-arm trial followed 63 adults with lower-grade gliomas treated with proton therapy. After five years, 79.1% of patients remained free from tumor progression. Overall survival reached 85.6%.
ROCHESTER — When Derek Gerlach, then 10 years old, was diagnosed with stage 4 brain cancer in November 2018, his treatment began almost immediately. Within a month, Derek underwent surgery to remove ...
LOS ANGELES (KABC) -- Proton therapy to treat prostate cancer has been available in Southern California for nearly 35 years. It's less invasive and offers fewer side effects compared to conventional ...
Mevion Medical Systems today announced that UNC Health, a leading academic health system based in North Carolina, has selected the MEVION S250-FIT (TM) Proton Therapy System, reinforcing the growing ...
Please provide your email address to receive an email when new articles are posted on . Men with low- or intermediate-risk prostate cancer achieved similar quality-of-life outcomes whether they ...